NYSE:GMED

Globus Medical Stock Insider Trading

Healthcare > Medical - Devices

Buy GMED

*Your capital is at risk

$80.86

-1.66 (-2.01%)

At Close: Jun 10, 2026

Globus Medical Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -8.10. In total, the insiders bought 1.92M and sold 184.24K GMED shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-8.10
● Buy	1.92M shares
● Sell	184.24K shares
84% Buy Activity Negligible or No Correlation
Sell Signal Low Confidence Jun 05, 2026 Analysis Breakdown: Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jan 08, 2026 Buy	Class A Common Stock M-Exempt	Kline Kyle Senior Vice President, CFO	CEO / President	3 594 Value: $186.4K
Jan 08, 2026 Sell	Class A Common Stock S-Sale	Kline Kyle Senior Vice President, CFO	CEO / President	3 594 Value: $363.4K
Jan 08, 2026 Sell	Class A Common Stock S-Sale	Norwalk Leslie V Director	Director	2 000 Value: $202.2K
Dec 12, 2025 Sell	Class A Common Stock S-Sale	Norwalk Leslie V Director	Director	4 000 Value: $355.4K
Dec 08, 2025 Buy	Class A Common Stock M-Exempt	Paul David C Executive Chairman	CEO / President	34 375 Value: $877.3K
Dec 08, 2025 Buy	Stock Option (Right to Buy Class A Common Stock) M-Exempt	Paul David C Executive Chairman	CEO / President	34 375 Value: $877.3K
Dec 01, 2025 Buy	Stock Option (Right to Buy Class A Common Stock) M-Exempt	Kline Kyle Senior Vice President, CFO	CEO / President	4 896 Value: $311.8K
Dec 01, 2025 Buy	Stock Option (Right to Buy Class A Common Stock) M-Exempt	Kline Kyle Senior Vice President, CFO	CEO / President	5 000 Value: $322.2K
Dec 01, 2025 Sell	Class A Common Stock S-Sale	Kline Kyle Senior Vice President, CFO	CEO / President	18 542 Value: $1.67M
Dec 01, 2025 Buy	Stock Option (Right to Buy Class A Common Stock) M-Exempt	Kline Kyle Senior Vice President, CFO	CEO / President	5 000 Value: $318.4K
Dec 01, 2025 Buy	Stock Option (Right to Buy Class A Common Stock) M-Exempt	Kline Kyle Senior Vice President, CFO	CEO / President	3 646 Value: $193.7K
Dec 01, 2025 Buy	Class A Common Stock M-Exempt	Kline Kyle Senior Vice President, CFO	CEO / President	3 646 Value: $193.7K
Dec 01, 2025 Buy	Class A Common Stock M-Exempt	Kline Kyle Senior Vice President, CFO	CEO / President	5 000 Value: $282.2K
Dec 01, 2025 Buy	Stock Option (Right to Buy Class A Common Stock) M-Exempt	Kline Kyle Senior Vice President, CFO	CEO / President	5 000 Value: $282.2K
Dec 01, 2025 Buy	Class A Common Stock M-Exempt	Kline Kyle Senior Vice President, CFO	CEO / President	5 000 Value: $322.2K
Dec 01, 2025 Buy	Class A Common Stock M-Exempt	Kline Kyle Senior Vice President, CFO	CEO / President	4 896 Value: $311.8K
Nov 25, 2025 Buy	Stock Option (Right to Buy Class A Common Stock) M-Exempt	Huller Kelly SVP, GC, Corporate Secretary	Officer	7 500 Value: $194.7K
Nov 25, 2025 Sell	Class A Common Stock S-Sale	Huller Kelly SVP, GC, Corporate Secretary	Officer	7 500 Value: $675.0K
Nov 25, 2025 Buy	Class A Common Stock M-Exempt	Huller Kelly SVP, GC, Corporate Secretary	Officer	7 500 Value: $194.7K
Nov 12, 2025 Buy	Class A Common Stock M-Exempt	Davidar David D Director	Director	25 000 Value: $638.0K
Nov 12, 2025 Sell	Class A Common Stock S-Sale	Davidar David D Director	Director	25 000 Value: $2.15M
Nov 12, 2025 Buy	Stock Option (Right to Buy Class A Common Stock) M-Exempt	Davidar David D Director	Director	25 000 Value: $638.0K
Nov 11, 2025 Buy	Stock Option (Right to Buy Class A Common Stock) M-Exempt	Zarrilli Stephen T Director	Director	25 000 Value: $1.10M
Nov 11, 2025 Sell	Class A Common Stock S-Sale	Zarrilli Stephen T Director	Director	25 000 Value: $2.11M
Nov 11, 2025 Buy	Class A Common Stock M-Exempt	Zarrilli Stephen T Director	Director	25 000 Value: $1.10M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT GLOBUS MEDICAL INC

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion p...

Read Full Profile Here